| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989375 Contacting a target cell with DNA-damaging agent; removing DNA-damaging agent from target cell; transferring transgene into target cell between about 1-3 days after removing DNA-damaging agent |
| 01/24/2006 | US6989373 By injecting a biocompatible solution, with a given intrinsic viscosity, similar to a fatty acid mixture normally present in a healthy fat pad; treating heel pain |
| 01/24/2006 | US6989370 bacteriocin produced by a Paenibacillus polymyxa strain having the identifying characteristics of strain NRRL B-30507; use in control of disease in animals, especially poultry |
| 01/24/2006 | US6989369 Kunitz domain peptides |
| 01/24/2006 | US6989367 OBG3 globular head and uses thereof |
| 01/24/2006 | US6989366 Exendins, exendin agonists, and methods for their use |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989364 treatment extends to all stages of progression of cardiac hypertrophy, with or without structural damage of the heart muscle, regardless of the underlying cardiac disorder |
| 01/24/2006 | US6989363 Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| 01/24/2006 | US6989270 Using polyamide nucleic acid oligomers to engender a biological response |
| 01/24/2006 | US6989268 Comprises deletion in adenovirus-2 early region 1A gene; for expression of a protein effective in regulating the cell cycle (such as p53, mitosin, or thymidine kinase suicide genes); tumor suppressor genes/proteins |
| 01/24/2006 | US6989267 Methods of making microarrays with substrate surfaces having covalently bound polyelectrolyte films |
| 01/24/2006 | US6989264 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 01/24/2006 | US6989262 Plasmin variants and uses thereof |
| 01/24/2006 | US6989258 DNA encoding a plant deoxyhpusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 01/24/2006 | US6989247 Compositions and methods for diagnosing or treating psoriasis |
| 01/24/2006 | US6989244 Method for screening compounds inhibiting signal transduction through inflammatory cytokines |
| 01/24/2006 | US6989232 Methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins |
| 01/24/2006 | US6989147 Tumor necrosis factor receptor protein for use in the treatment of arthritis |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989144 Glycoprotein VI antibodies and uses thereof |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/24/2006 | CA2270868C Method to detect ige |
| 01/24/2006 | CA2259499C Process for separating alpha-1-proteinase inhibitor from cohn fraction iv1 +iv4 paste |
| 01/23/2006 | WO2007015691A2 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/23/2006 | CA2586086A1 Furin inhibitors |
| 01/21/2006 | CA2512515A1 Super-antigen fusion proteins and the use thereof |
| 01/19/2006 | WO2006007555A2 Rotavirus antigens |
| 01/19/2006 | WO2006007509A2 Epidermal growth factor receptor antagonists and methods of use |
| 01/19/2006 | WO2006007202A2 Canine cd20 compositions |
| 01/19/2006 | WO2006006722A1 Method of controlling cell functions |
| 01/19/2006 | WO2006006693A1 Anti-glypican 3 antibody |
| 01/19/2006 | WO2006006074A2 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 01/19/2006 | WO2006005943A1 Phage screening assay |
| 01/19/2006 | WO2006005934A1 Recombinant marek’s disease virus |
| 01/19/2006 | WO2006005825A2 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
| 01/19/2006 | WO2006005591A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005588A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005587A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005586A2 New polypeptide species specific to cerebrospinal fluid |
| 01/19/2006 | WO2006005585A2 Secreted polypeptide species differentially expressed during pregnancy |
| 01/19/2006 | WO2006005582A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2006005535A1 Reagents for diagnosis and therapy of latex allergy and method for the preparation of the same |
| 01/19/2006 | WO2006005520A2 Means and methods for controlling flowering in plants |
| 01/19/2006 | WO2006005473A2 Rat trace amine associated receptors |
| 01/19/2006 | WO2006005472A1 Diagnostics and therapeutics for diseases associated with vanilloid receptor 1 (vr1) |
| 01/19/2006 | WO2006005471A1 Diagnostics and therapeutics for diseases associated with vanilloid receptor 2 (vr2(vrl-1)) |
| 01/19/2006 | WO2006005268A2 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 01/19/2006 | WO2005116074A3 Nucleoproteins displaying native t cell receptor libraries |
| 01/19/2006 | WO2005100564A3 Intervention in the energy metabolism of eukaryote cells for the purposes of selection and increased expression |
| 01/19/2006 | WO2005094543A3 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
| 01/19/2006 | WO2005086947A3 Method for inhibiting immune complex formation in a subjetc |
| 01/19/2006 | WO2005079315A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 01/19/2006 | WO2005065268A3 Oligonucleotide compound and method for treating nidovirus infections |
| 01/19/2006 | WO2004096841A8 Glut-1 as a receptor for htlv envelopes and its uses |
| 01/19/2006 | WO2004094620A3 Truncated baff receptors |
| 01/19/2006 | WO2004092398A3 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 01/19/2006 | WO2004072267A3 Enzymes |
| 01/19/2006 | WO2004072226A3 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells |
| 01/19/2006 | WO2004042001A3 Virus-like particles, methods of preparation, and immonogenic compositions |
| 01/19/2006 | WO2003087313A3 Enhanced silk exsertion under stress |
| 01/19/2006 | WO2003042361A3 Production of adeno-associated virus in insect cells |
| 01/19/2006 | US20060015972 Plant transcriptional regulators of drought stress |
| 01/19/2006 | US20060015970 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/19/2006 | US20060015969 Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/19/2006 | US20060015954 GPR54 knock-out mammals and screening methods using them |
| 01/19/2006 | US20060015951 Proteins involved in the regulation of energy homeostasis |
| 01/19/2006 | US20060014942 Nucleotide sequences for the control of the expression of DNA sequences in a cell host |
| 01/19/2006 | US20060014941 Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same |
| 01/19/2006 | US20060014940 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014935 Fas ligand derived polypeptides |
| 01/19/2006 | US20060014934 Crystal structure of factor Vai and method for identifying blood factor Va modulators |
| 01/19/2006 | US20060014933 Using amines or amino acids as mobile phase modifiers in chromatography |
| 01/19/2006 | US20060014932 Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same |
| 01/19/2006 | US20060014931 Novel promoter |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014929 Liquid phase peptide synthesis of KL-4 pulmonary surfactant |
| 01/19/2006 | US20060014928 Scorpion peptide as hypotensive agent |
| 01/19/2006 | US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 01/19/2006 | US20060014711 Methods for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 01/19/2006 | US20060014696 Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
| 01/19/2006 | US20060014693 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 01/19/2006 | US20060014692 Methods of using non-human animal Apoliprotein A-I protein |
| 01/19/2006 | US20060014691 Mechanically activated channel blocker |
| 01/19/2006 | US20060014690 EGFR ligand polypeptide variants; inhibition of the receptor's kinase activation activity and subsequently, cell proliferation |
| 01/19/2006 | US20060014688 Methods of inhibiting tumor cell proliferation |
| 01/19/2006 | US20060014687 Bone delivery conjugates and method of using same to target proteins to bone |
| 01/19/2006 | US20060014685 Treating a disease or condition associated with a disorder of glucose metabolism; diabetes mellitus of Type I or Type II, insulin resistance |
| 01/19/2006 | US20060014683 Procoagulant protein comprising polypeptide with amino acid substitutions; resistant to activated protein C; von Willebrand factor binding site deleted and thrombin cleavage site is mutated; treating hemophilia |
| 01/19/2006 | US20060014682 Chemokine receptor antagonist peptide with a sequence homologous to SDF-1 wherein at least one amino acid at positions five to eight are substituted with proline; proliferative agents; self-regeneration of stem cells |
| 01/19/2006 | US20060014681 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 01/19/2006 | US20060014679 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 01/19/2006 | US20060014673 Kappa-A conopeptides and uses therefor |
| 01/19/2006 | US20060014668 Antigenic gp 100 compounds for therapy and diagnosis and methods of using same |
| 01/19/2006 | US20060014667 Peptide composition and method for delivering substances into the cytosol of cells |
| 01/19/2006 | US20060014666 Water-solubility macromolecule conjugate with interferon; polyoxyethylene glycol, polyoxypropylene glycol or copolymers; one end group having a glucose attached, the other an interferon; long physiological cycle half-life; bioavailability; binds to asialoglycoprotein receptors on liver; hepititis B/C |
| 01/19/2006 | US20060014277 Novel human kielin-like proteins and polynucleotides encoding the same |
| 01/19/2006 | US20060014276 Chimeric adenoviruses |